{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:43:18Z","timestamp":1771918998973,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS079429"],"award-info":[{"award-number":["R01NS079429"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006751","name":"U.S. Army","doi-asserted-by":"publisher","award":["TS130067"],"award-info":[{"award-number":["TS130067"]}],"id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009528","name":"Children\u2019s Hospital of Michigan Foundation","doi-asserted-by":"publisher","award":["R2-2016-46"],"award-info":[{"award-number":["R2-2016-46"]}],"id":[{"id":"10.13039\/100009528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neuroinflammation and toll-like receptors (TLR) of the innate immune system have been implicated in epilepsy. We previously reported high levels of microRNAs miR-142-3p and miR-223-3p in epileptogenic brain tissue resected for the treatment of intractable epilepsy in children with tuberous sclerosis complex (TSC). As miR-142-3p has recently been reported to be a ligand and activator of TLR7, a detector of exogenous and endogenous single-stranded RNA, we evaluated TLR7 expression and downstream IL23A activation in surgically resected TSC brain tissue.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Gene expression analysis was performed on cortical tissue obtained from surgery of TSC children with pharmacoresistent epilepsy. Expression of TLRs 2, 4 and 7 was measured using NanoString nCounter assays. Real-time quantitative PCR was used to confirm TLR7 expression and compare TLR7 activation, indicated by IL-23A levels, to levels of miR-142-3p. Protein markers characteristic for TLR7 activation were assessed using data from our existing quantitative proteomics dataset of TSC tissue. Capillary electrophoresis Western blots were used to confirm TLR7 protein expression in a subset of samples.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>TLR7 transcript expression was present in all TSC specimens. The signaling competent form of TLR7 protein was detected in the membrane fraction of each sample tested. Downstream activation of TLR7 was found in epileptogenic lesions having elevated neuroinflammation indicated by clinical neuroimaging. TLR7 activity was significantly associated with tissue levels of miR-142-3p.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>TLR7 activation by microRNAs may contribute to the neuroinflammatory cascade in epilepsy in TSC. Further characterization of this mechanism may enable the combined of use of neuroimaging and TLR7 inhibitors in a personalized approach towards the treatment of intractable epilepsy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00011-019-01283-3","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T08:02:51Z","timestamp":1568188971000},"page":"993-998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["TLR7 activation in epilepsy of tuberous sclerosis complex"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0312-8750","authenticated-orcid":false,"given":"Alan A.","family":"Dombkowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Cukovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Bagla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"McKenzie","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry T.","family":"Chugani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane C.","family":"Chugani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"1283_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","volume":"244","author":"A Vezzani","year":"2013","unstructured":"Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Exp Neurol. 2013;244:11\u201321.","journal-title":"Exp Neurol"},{"key":"1283_CR2","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1111\/j.1528-1167.2011.03103.x","volume":"52","author":"HT Chugani","year":"2011","unstructured":"Chugani HT, Kumar A, Kupsky W, Asano E, Sood S, Juhasz C. Clinical and histopathologic correlates of 11C-alpha-methyl-l-tryptophan (AMT) PET abnormalities in children with intractable epilepsy. Epilepsia. 2011;52:1692\u20138.","journal-title":"Epilepsia"},{"key":"1283_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2217\/bmm.11.73","volume":"5","author":"DC Chugani","year":"2011","unstructured":"Chugani DC. Alpha-methyl-l-tryptophan: mechanisms for tracer localization of epileptogenic brain regions. Biomark Med. 2011;5:567\u201375.","journal-title":"Biomark Med"},{"key":"1283_CR4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11307-009-0225-0","volume":"11","author":"CE Batista","year":"2009","unstructured":"Batista CE, Juhasz C, Muzik O, Kupsky WJ, Barger G, Chugani HT, et al. Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors. Mol Imaging Biol. 2009;11:460\u20136.","journal-title":"Mol Imaging Biol"},{"key":"1283_CR5","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/neuonc\/nov225.38","volume":"17","author":"E Bosnyak","year":"2015","unstructured":"Bosnyak E, Kamson DO, Guastella AR, Varadarajan K, Robinette NL, Kupsky WJ, et al. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas. Neuro-Oncology. 2015;17:1284\u201392.","journal-title":"Neuro-Oncology"},{"key":"1283_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.nbd.2017.10.004","volume":"109","author":"SCD Bagla","year":"2018","unstructured":"Bagla SCD, Asano E, Sood S, Luat A, Chugani H, Chugani D, Dombkowski A. A distinct microRNA expression profile is associated with alpha[11C]-methyl-l-tryptophan (AMT) PET uptake in epileptogenic cortical tubers resected from patients with tuberous sclerosis complex. Neurobiol Dis. 2018;109:76\u201387.","journal-title":"Neurobiol Dis."},{"key":"1283_CR7","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.4049\/jimmunol.1700730","volume":"199","author":"Y Feng","year":"2017","unstructured":"Feng Y, Zou L, Yan D, Chen H, Xu G, Jian W, et al. Extracellular microRNAs induce potent innate immune responses via TLR7\/MyD88-dependent mechanisms. J Immunol. 2017;199:2106\u201317.","journal-title":"J Immunol"},{"key":"1283_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1189\/jlb.4A0714-339R","volume":"97","author":"AC Love","year":"2015","unstructured":"Love AC, Schwartz I, Petzke MM. Induction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential. J Leukoc Biol. 2015;97:379\u201390.","journal-title":"J Leukoc Biol"},{"key":"1283_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1476-9255-7-37","volume":"7","author":"SS Jensen","year":"2010","unstructured":"Jensen SS, Gad M. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity. J Inflamm (Lond). 2010;7:37.","journal-title":"J Inflamm (Lond)"},{"key":"1283_CR10","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/brain\/awr032","volume":"134","author":"E Zurolo","year":"2011","unstructured":"Zurolo E, Iyer A, Maroso M, Carbonell C, Anink JJ, Ravizza T, et al. Activation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain. 2011;134:1015\u201332.","journal-title":"Brain"},{"key":"1283_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.intimp.2007.04.006","volume":"7","author":"TK Ghosh","year":"2007","unstructured":"Ghosh TK, Mickelson DJ, Solberg JC, Lipson KE, Inglefield JR, Alkan SS. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha. Int Immunopharmacol. 2007;7:1111\u201321.","journal-title":"Int Immunopharmacol"},{"key":"1283_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10616-009-9249-1","volume":"61","author":"S Bunger","year":"2009","unstructured":"Bunger S, Roblick UJ, Habermann JK. Comparison of five commercial extraction kits for subsequent membrane protein profiling. Cytotechnology. 2009;61:153\u20139.","journal-title":"Cytotechnology"},{"key":"1283_CR13","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1084\/jem.20131044","volume":"210","author":"C Guiducci","year":"2013","unstructured":"Guiducci C, Gong M, Cepika AM, Xu Z, Tripodo C, Bennett L, et al. RNA recognition by human TLR8 can lead to autoimmune inflammation. J Exp Med. 2013;210:2903\u201319.","journal-title":"J Exp Med"},{"key":"1283_CR14","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/cercor\/bhu276","volume":"26","author":"AA Dombkowski","year":"2016","unstructured":"Dombkowski AA, Batista CE, Cukovic D, Carruthers NJ, Ranganathan R, Shukla U, et al. Cortical tubers: windows into dysregulation of epilepsy risk and synaptic signaling genes by microRNAs. Cereb Cortex. 2016;26:1059\u201371.","journal-title":"Cereb Cortex"},{"key":"1283_CR15","first-page":"R1","volume":"16","author":"PF Smith","year":"2017","unstructured":"Smith PF. A guerilla guide to common problems in \u2018neurostatistics\u2019: essential statistical topics in neuroscience. J Undergrad Neurosci Educ. 2017;16:R1\u201312.","journal-title":"J Undergrad Neurosci Educ"},{"key":"1283_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3389\/fimmu.2017.01075","volume":"8","author":"C Petes","year":"2017","unstructured":"Petes C, Odoardi N, Gee K. The toll for trafficking: toll-like receptor 7 delivery to the endosome. Front Immunol. 2017;8:1075.","journal-title":"Front Immunol"},{"key":"1283_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.immuni.2013.09.004","volume":"39","author":"MM Hipp","year":"2013","unstructured":"Hipp MM, Shepherd D, Gileadi U, Aichinger MC, Kessler BM, Edelmann MJ, et al. Processing of human toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes. Immunity. 2013;39:711\u201321.","journal-title":"Immunity"},{"key":"1283_CR18","doi-asserted-by":"publisher","first-page":"e1002841","DOI":"10.1371\/journal.ppat.1002841","volume":"8","author":"S Maschalidi","year":"2012","unstructured":"Maschalidi S, Hassler S, Blanc F, Sepulveda FE, Tohme M, Chignard M, et al. Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation. PLoS Pathog. 2012;8:e1002841.","journal-title":"PLoS Pathog"},{"key":"1283_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1074-7613(02)00390-4","volume":"17","author":"S Doyle","year":"2002","unstructured":"Doyle S, Vaidya S, O\u2019Connell R, Dadgostar H, Dempsey P, Wu T, et al. IRF3 mediates a TLR3\/TLR4-specific antiviral gene program. Immunity. 2002;17:251\u201363.","journal-title":"Immunity"},{"key":"1283_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.4049\/jimmunol.168.2.554","volume":"168","author":"KA Zarember","year":"2002","unstructured":"Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol. 2002;168:554\u201361.","journal-title":"J Immunol"},{"key":"1283_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.placenta.2015.06.017","volume":"36","author":"S Patni","year":"2015","unstructured":"Patni S, Bryant AH, Wynen LP, Seager AL, Morgan G, Thornton CA. Functional activity but not gene expression of toll-like receptors is decreased in the preterm versus term human placenta. Placenta. 2015;36:1031\u20138.","journal-title":"Placenta"},{"key":"1283_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.seizure.2013.04.023","volume":"22","author":"K Pernhorst","year":"2013","unstructured":"Pernhorst K, Herms S, Hoffmann P, Cichon S, Schulz H, Sander T, et al. TLR4, ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epileptic brain tissue. Seizure. 2013;22:675\u20138.","journal-title":"Seizure"},{"key":"1283_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jneuroim.2017.10.014","volume":"313","author":"B Leal","year":"2017","unstructured":"Leal B, Chaves J, Carvalho C, Rangel R, Santos A, Bettencourt A, et al. Brain expression of inflammatory mediators in mesial temporal lobe epilepsy patients. J Neuroimmunol. 2017;313:82\u20138.","journal-title":"J Neuroimmunol"},{"key":"1283_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1189\/jlb.1A1014-519RR","volume":"98","author":"JB Fordham","year":"2015","unstructured":"Fordham JB, Naqvi AR, Nares S. Regulation of miR-24, miR-30b, and miR-142-3p during macrophage and dendritic cell differentiation potentiates innate immunity. J Leukoc Biol. 2015;98:195\u2013207.","journal-title":"J Leukoc Biol"},{"key":"1283_CR25","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.4049\/jimmunol.1202911","volume":"190","author":"Y Sun","year":"2013","unstructured":"Sun Y, Sun J, Tomomi T, Nieves E, Mathewson N, Tamaki H, et al. PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6. J Immunol. 2013;190:4005\u201313.","journal-title":"J Immunol"},{"key":"1283_CR26","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","volume":"186","author":"A Kuznik","year":"2011","unstructured":"Kuznik A, Bencina M, Svajger U, Jeras M, Rozman B, Jerala R. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J Immunol. 2011;186:4794\u2013804.","journal-title":"J Immunol"},{"key":"1283_CR27","doi-asserted-by":"publisher","first-page":"e47357","DOI":"10.1371\/journal.pone.0047357","volume":"7","author":"E Firat","year":"2012","unstructured":"Firat E, Weyerbrock A, Gaedicke S, Grosu AL, Niedermann G. Chloroquine or chloroquine-PI3\u00a0K\/Akt pathway inhibitor combinations strongly promote gamma-irradiation-induced cell death in primary stem-like glioma cells. PLoS One. 2012;7:e47357.","journal-title":"PLoS One"},{"key":"1283_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0041-008X(79)90498-8","volume":"50","author":"NG Osifo","year":"1979","unstructured":"Osifo NG. The regional uptake of chloroquine in the rat brain. Toxicol Appl Pharmacol. 1979;50:109\u201314.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1283_CR29","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/aps.2015.91","volume":"36","author":"YW Wu","year":"2015","unstructured":"Wu YW, Tang W, Zuo JP. Toll-like receptors: potential targets for lupus treatment. Acta Pharmacol Sin. 2015;36:1395\u2013407.","journal-title":"Acta Pharmacol Sin"},{"key":"1283_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrd3203","volume":"9","author":"EJ Hennessy","year":"2010","unstructured":"Hennessy EJ, Parker AE, O\u2019Neill LA. Targeting toll-like receptors: emerging therapeutics? Nat Rev Drug Discov. 2010;9:293\u2013307.","journal-title":"Nat Rev Drug Discov"},{"key":"1283_CR31","doi-asserted-by":"publisher","first-page":"7807313","DOI":"10.1155\/2017\/7807313","volume":"2017","author":"CY Lai","year":"2017","unstructured":"Lai CY, Su YW, Lin KI, Hsu LC, Chuang TH. Natural modulators of endosomal toll-like receptor-mediated psoriatic skin inflammation. J Immunol Res. 2017;2017:7807313.","journal-title":"J Immunol Res"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-019-01283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-019-01283-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-019-01283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T17:47:16Z","timestamp":1599760036000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-019-01283-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1283"],"URL":"https:\/\/doi.org\/10.1007\/s00011-019-01283-3","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]},"assertion":[{"value":"31 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}